해당화 추출물을 유효성분으로 함유하는 운동성 육체적 스트레스 관련 질환의 치료 및 예방을 위한 조성물
    2.
    发明公开
    해당화 추출물을 유효성분으로 함유하는 운동성 육체적 스트레스 관련 질환의 치료 및 예방을 위한 조성물 有权
    包含ROSA RUGOSA提取物或治疗物理应激性疾病的组合物和功能性食品

    公开(公告)号:KR1020140046233A

    公开(公告)日:2014-04-18

    申请号:KR1020120112449

    申请日:2012-10-10

    CPC classification number: A61K36/738 A23V2200/322 A61K2236/331

    Abstract: The present invention relates to a composition comprising an extract of Rosa rugosa stem and leaves and, more specifically, to a pharmaceutical composition and a functional health food for suppressing, preventing, and alleviating stress-related diseases caused by a lack of sleep which comprises a powder or an extract obtainable by extracting and concentrating Rosa rugosa stem and leaves by using various solvents. The extract of Rosa rugosa stem and leaves according to the present invention is confirmed to have excellent effects for increasing survival rate, reducing drowsing, reducing cortisol content, and protecting nerve cells against sleep deprivation in rats.

    Abstract translation: 本发明涉及一种组合物,其包含罗莎蔷薇茎和叶的提取物,更具体地涉及用于抑制,预防和减轻由睡眠不足引起的与压力有关的疾病的药物组合物和功能保健食品,其包含 粉末或通过使用各种溶剂提取和浓缩罗莎蔷薇茎叶而获得的提取物。 确认本发明的罗莎芦苇提取物对提高存活率,降低呕吐,降低皮质醇含量,保护神经细胞免受大鼠睡眠剥夺的作用具有优异的效果。

    1―테트라데칸올을 포함하는 면역 억제 조성물
    4.
    发明授权
    1―테트라데칸올을 포함하는 면역 억제 조성물 有权
    包含1-十四醇的免疫抑制组合物

    公开(公告)号:KR101771129B1

    公开(公告)日:2017-08-28

    申请号:KR1020160089434

    申请日:2016-07-14

    Abstract: 본발명은 -테트라데칸올(1-tetradecanol)을유효성분으로포함하는면역억제조성물에관한것이다. 본발명의면역억제조성물의유효성분인 1-테트라데칸올은황칠나무의잎으로부터추출분리된성분으로서, T세포의증식억제효과가매우우수하여면역억제제로서사용할수 있다. 또한본 발명의면역억제조성물은염증성전사인자 NF-kB의억제효과, IL-2 사이토카인생산억제효과및 접촉성피부염에대한항염증효과를가지므로자가면역질환및 염증질환의치료조성물로사용할수 있다.

    Abstract translation: 本发明涉及包含十四烷醇作为活性成分的免疫抑制组合物。 免疫组合物的活性成分是本发明的作为从树hwangchil的叶子中提取的单独部件的,也可以在T细胞的增殖抑制效果可以使用1-四癸醇是作为免疫抑制剂非常优异。 另外,根据本发明的免疫组合物对炎症转录因子NF-kB的作用受到抑制的抗炎作用,IL-2细胞因子产生抑制效果和接触性皮炎,可以用作自身免疫疾病和炎性疾病的治疗组合物 有。

    발효울금 분말을 함유한 알코올성 간손상 보호용 조성물
    6.
    发明公开
    발효울금 분말을 함유한 알코올성 간손상 보호용 조성물 无效
    包含发酵的CURCUMA LONGA L的粉末的组合物,用于保护酒精性肝脏损伤

    公开(公告)号:KR1020140026737A

    公开(公告)日:2014-03-06

    申请号:KR1020120092198

    申请日:2012-08-23

    Abstract: The present invention relates to a composition containing fermented Curcuma longa powder for treating alcoholic liver damage. The fermented Curcuma longa powder of the present invention is obtained by fermenting materials for the fermented Curcuma longa powder using Aspergillus oryzae, and sterilizing and drying the materials, and shows a strong liver damage control function in an alcoholic liver damage model. The composition can be practically used for treatment and prevention food for alcoholic liver damage, medical products, and outer medical products using the fermented Curcuma longa powder.

    Abstract translation: 本发明涉及含有用于治疗酒精性肝损伤的发酵姜黄粉的组合物。 本发明的发酵姜黄粉是通过使用米曲霉发酵的姜黄发酵材料进行发酵而得到的,对该材料进行灭菌干燥,在酒精性肝损伤模型中显示出强烈的肝损伤控制功能。 该组合物可用于治疗和预防酒精性肝损伤的食物,医疗产品和使用发酵的姜黄粉的外用医药产品。

Patent Agency Ranking